首页> 外文期刊>Journal of Medicinal Chemistry >Structure-Activity Relationships Studies in a Series of N,N-Bis(alkanol)amine Aryl Esters as P-Glycoprotein (Pgp) Dependent Multidrug Resistance (MDR) Inhibitors
【24h】

Structure-Activity Relationships Studies in a Series of N,N-Bis(alkanol)amine Aryl Esters as P-Glycoprotein (Pgp) Dependent Multidrug Resistance (MDR) Inhibitors

机译:一系列N,N-双(链烷醇)胺芳基酯作为P-糖蛋白(Pgp)依赖性多药耐药(MDR)抑制剂的结构-活性关系研究

获取原文
获取原文并翻译 | 示例
           

摘要

As a continuation Or a previous research, a series of N,N-bis(alkanol)amine aryl esters, as Pgp-dependent MDR inhibitors, was; designed and synthesized. The aromatic ester portions are suitably modulated, and new aryl rings (Ar-1 and Ar-2) were combined with trans-3-(3,4,5-trimethoxyphenyl)-vinyl, 3,4,5-trimethoxybenzyl and anthracene moieties that were present in the most potent previously Studied compounds. The new compounds showed I wide range of potencies and efficacies Oil doxorubicin-resistant erythroleukemia K562 cells (K562/DOX) in the pirarubicin uptake assay. Selected compounds (5, 6, 8, 9, and 21) were further Studied, evaluating their action on doxorubicin cytotoxicity potentiation oil K562 cells; they significantly enhanced doxorubicin cytotoxicity oil K562/DOX cells, confirming the results obtained with pirarubicin. Compound 9 Shows file Most promising properties as it was able to nearly completely reverse Pgp-dependent pirarubicin extrusion at nanomolar closes and increased the cytotoxicity of doxorubicin with a reversal fold (RF) of 19.1 at 3 mu M dose.
机译:作为一项继续研究或先前的研究,人们开发了一系列依赖于Pgp的MDR抑制剂N,N-双(链烷醇)胺芳基酯。设计和合成。适当地调节芳族酯部分,并将新的芳基环(Ar-1和Ar-2)与反式-3-(3,4,5-三甲氧基苯基)-乙烯基,3,4,5-三甲氧基苄基和蒽部分结合最有效的先前研究过的化合物中存在的化合物。新化合物在吡柔比星摄取试验中显示出广泛的效价和功效,可耐受耐油阿霉素的红白血病K562细胞(K562 / DOX)。进一步研究了选定的化合物(5、6、8、9和21),评估了它们对阿霉素细胞毒性增强油K562细胞的作用;它们显着增强了阿霉素的细胞毒性油K562 / DOX细胞,证实了吡柔比星获得的结果。化合物9显示了文件最有希望的性质,因为它能够在纳摩尔结束时几乎完全逆转Pgp依赖的吡柔比星挤出,并在3μM剂量下具有19.1的逆向折叠(RF),增加了阿霉素的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号